Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medimetriks Pharmaceuticals Inc.

This article was originally published in Start Up

Executive Summary

Go with what you know. This familiar adage is plainly influencing the strategy of Medimetriks Pharmaceuticals, a dermatology-products start-up now being managed by key team members from the former Bradley Pharmaceuticals. The firm says it is already cash-flow positive, on the strength of a portfolio that was assembled in just six months or so. Medimetriks' business strategy is a straightforward specialty pharma marketing scheme: the plan is to quickly build the company on the back of products that are familiar to specialized physicians that management can reach with small sales forces.

Related Companies

Related Deals

Latest Headlines
See All
UsernamePublicRestriction

Register

SC091790

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel